SearchBrowseExplore
Search
Statistics
| India | 1019 |
| Turkey | 313 |
| Indonesia | 248 |
| United States of America | 226 |
| Ukraine | 183 |
Home >
Name |
: | American Journal of Advanced Drug delivery |
eISSN |
: | 2321-547X |
pISSN |
: | XXXX-XXXX |
JIFACTOR |
: | Under Evalution |
Subject |
: | Life Sciences |
| Description American Journal of Advanced Drug Delivery is an open access, peer-reviewed journal that considers articles on the Drug Delivery & Research.The goal of this journal is to keep a record of the state-of-the-art research and to promote study, research and improvement within its various specialties. All manuscripts submitted to AJADD must be previously unpublished and may not be considered for publication elsewhere at any time during AJADD's review period. Topics to be covered by this journal include, but are not limited to: All delivery systems and modes of entry; Controlled-release systems; Sustain release systems; Microcapsules/microparticles; Liposomes; Vesicles and macromolecular conjugates; Antibody targeting; Protein/peptide delivery; Drug Targeting; Process design, optimization of drug delivery system; Materials science; Controlled-release/ Sustain release systems; Nanopharmaceuticals; Nanocrystals; Inorganic, lipid and polymeric nanocarriers, liposomes and nanoemulsions; Design of nanocarriers for theranostics and tissue engineering applications; Tools used for characterization of pharmaceutical nanocarriers and processes; Nanotechnology tools used in drug discovery and development; Nanosolubilization techniques, transport processes across various drug delivery barriers; Cellular transport; Bopharmaceutics and pharmacokinetics of nanomaterials and drug delivery systems; Molecular design of polymeric-drug conjugates, prodrugs; Nanoscale fabrication of drug delivery devices; Optimization, scale-up and manufacturing aspects of pharmaceutical nanotechnology; In-vitro and In-vivo characterization of pharmaceutical nanocarriers, nanodevices; Safety and biocompatibility of nanocarriers and drug delivery systems; Regulatory aspects and policies related to development, evaluation and control of nanopharmaceuticals. | ||
| Website Click To View Website | ||
| Publish By Tiba Pharmaceuticals Pvt. Ltd. | ||